Trial Profile
A Single-centre, Open-label, Randomised, Cross-over, Drug-drug Interaction Study to Investigate the Effect of Repeated Oral Doses of Ciclosporin on the Single-dose Pharmacokinetics of nASP2151 in Healthy Men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2019
Price :
$35
*
At a glance
- Drugs Amenamevir (Primary) ; Ciclosporin
- Indications Herpes simplex virus infections; Herpes zoster
- Focus Pharmacokinetics
- Sponsors Maruho
- 17 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Nov 2014 New trial record